TWIST1 and breast carcinoma: Several studies have suggested that Twist1 is associated with pathways in the EMT process such as Wnt/β-catenin signaling [24], PI3K/AKT/TGF-β signaling [25, 26], AKT2 signaling [20], and NF-κB signaling[21] in breast cancer cells.